首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Nocardia beijingensis pulmonary infection successfully treated with intravenous beta-lactam antibiotics and oral minocycline.
【24h】

Nocardia beijingensis pulmonary infection successfully treated with intravenous beta-lactam antibiotics and oral minocycline.

机译:北京诺卡氏菌肺部感染已成功通过静脉内使用β-内酰胺类抗生素和口服米诺环素治疗。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report a case of pulmonary infection caused by a rare Nocardia species, Nocardia beijingensis, in a 48-year-old man who received multiple immunosuppressive therapy after renal transplantation. This pathogen was isolated from a bronchoscopic protected specimen brush and was identified as N. beijingensis by 16S rRNA gene sequence analysis. The patient was initially treated with imipenem/cilastatin followed by ceftriaxone and oral minocycline. Traditionally, trimethoprim-sulfamethoxazole (SXT) has been one of the first-line antibiotics chosen as an initial therapy for pulmonary nocardiosis, but this case was successfully treated without SXT. Considering recent reports about failures of both prophylaxis and treatment for nocardial infections with SXT and its various side effects, treatment with beta-lactam antibiotics and minocycline for pulmonary nocardiosis can be chosen in mild to moderate cases with confirmed susceptibility to these antibiotics in vitro.
机译:我们报道了一个由罕见的诺卡氏菌物种北京诺卡氏菌引起的肺部感染病例,该患者是一名48岁的男性,他在肾移植后接受了多次免疫抑制治疗。从支气管镜保护的标本刷中分离出该病原体,并通过16S rRNA基因序列分析鉴定为北京猪笼草。该患者最初接受亚胺培南/西司他丁治疗,然后再使用头孢曲松和口服米诺环素治疗。传统上,甲氧苄氨嘧啶-磺胺甲基异恶唑(SXT)是被选作肺部心肌病初始治疗的一线抗生素之一,但此病例在没有SXT的情况下成功治疗。考虑到最近有关预防和治疗SXT心肌感染的失败及其各种副作用的报道,对于轻度至中度且已证实对体外抗生素敏感的病例,可以选择用β-内酰胺类抗生素和米诺环素治疗肺部心肌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号